BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 20090223)

  • 1. Significance of preoperative thrombocytosis in epithelial ovarian cancer.
    Crasta JA; Premlatha TS; Krishnan SM; Vallikad E; Rameshkumar K
    Indian J Pathol Microbiol; 2010; 53(1):54-6. PubMed ID: 20090223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic significance of thrombocytosis in epithelial ovarian carcinoma.
    Li AJ; Madden AC; Cass I; Leuchter RS; Lagasse LD; Karlan BY
    Gynecol Oncol; 2004 Jan; 92(1):211-4. PubMed ID: 14751160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombocytosis in advanced epithelial ovarian cancer.
    Soonthornthum T; Suraseraneewong V; Kengsakol K; Wijaithum K; Kasemsan P; Prommatt S
    J Med Assoc Thai; 2007 Aug; 90(8):1495-500. PubMed ID: 17926975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgen mediation of thrombocytosis in epithelial ovarian cancer biology.
    Li AJ; Karlan BY
    Clin Cancer Res; 2005 Nov; 11(22):8015-8. PubMed ID: 16299230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic significance of thrombocytosis in uterine papillary serous carcinomas.
    Lerner DL; Walsh CS; Cass I; Karlan BY; Li AJ
    Gynecol Oncol; 2007 Jan; 104(1):91-4. PubMed ID: 16934317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of thrombocytosis, platelet parameters and aggregation rates in epithelial ovarian cancer.
    Ma X; Wang Y; Sheng H; Tian W; Qi Z; Teng F; Xue F
    J Obstet Gynaecol Res; 2014 Jan; 40(1):178-83. PubMed ID: 24102732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of thrombocytosis in prognostic evaluation of epithelial ovarian tumors.
    Gungor T; Kanat-Pektas M; Sucak A; Mollamahmutoglu L
    Arch Gynecol Obstet; 2009 Jan; 279(1):53-6. PubMed ID: 18470520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new prognostic model for cancer-specific survival after radical cystectomy including pretreatment thrombocytosis and standard pathological risk factors.
    Todenhöfer T; Renninger M; Schwentner C; Stenzl A; Gakis G
    BJU Int; 2012 Dec; 110(11 Pt B):E533-40. PubMed ID: 22578156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
    Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML
    Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer.
    Bristow RE; Montz FJ; Lagasse LD; Leuchter RS; Karlan BY
    Gynecol Oncol; 1999 Mar; 72(3):278-87. PubMed ID: 10053096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombocytosis associated with malignant ovarian lesions within a pediatric/adolescent population.
    Haddad LB; Laufer MR
    J Pediatr Adolesc Gynecol; 2008 Oct; 21(5):243-6. PubMed ID: 18794018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative serum vascular endothelial growth factor levels: significance in ovarian cancer.
    Cooper BC; Ritchie JM; Broghammer CL; Coffin J; Sorosky JI; Buller RE; Hendrix MJ; Sood AK
    Clin Cancer Res; 2002 Oct; 8(10):3193-7. PubMed ID: 12374688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association of preoperative thrombocytosis with prognostic factors in malign ovarian tumor.
    Kuyumcuoglu U; Guzel AI; Celik Y; Erdemoğlu M
    Eur J Gynaecol Oncol; 2010; 31(5):514-6. PubMed ID: 21061791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Epithelial ovarian cancer--preoperative assessment of Ca 125 levels as an independent prognostic factor].
    Ivanov S; Ivanov S
    Akush Ginekol (Sofiia); 2003; 42(3):16-9. PubMed ID: 12858485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thresholds and timing of pre-operative thrombocytosis and ovarian cancer survival: analysis of laboratory measures from electronic medical records.
    Cozzi GD; Samuel JM; Fromal JT; Keene S; Crispens MA; Khabele D; Beeghly-Fadiel A
    BMC Cancer; 2016 Aug; 16():612. PubMed ID: 27502272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic significance of thrombocytosis in ovarian cancer.
    Słabuszewska-Jóźwiak A; Dmoch-Gajzlerska E; Kozakiewicz B; Jakiel G
    Ann Agric Environ Med; 2015; 22(4):731-5. PubMed ID: 26706987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of cell cycle regulatory proteins as malignant and prognostic biomarkers in ovarian epithelial tumors.
    Lee YH; Heo JH; Kim TH; Kang H; Kim G; Kim J; Cho SH; An HJ
    Int J Gynecol Pathol; 2011 May; 30(3):205-17. PubMed ID: 21464733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of thrombocytosis in patients with epithelial ovarian cancer.
    Zeimet AG; Marth C; Müller-Holzner E; Daxenbichler G; Dapunt O
    Am J Obstet Gynecol; 1994 Feb; 170(2):549-54. PubMed ID: 8116711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of preoperative hyponatremia and thrombocytosis in patients with epithelial ovarian cancer.
    Hefler-Frischmuth K; Grimm C; Gensthaler L; Reiser E; Schwameis R; Hefler LA
    Wien Klin Wochenschr; 2018 Oct; 130(19-20):575-580. PubMed ID: 30178070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of platelet count in patients with renal cell carcinoma.
    Erdemir F; Kilciler M; Bedir S; Ozgok Y; Coban H; Erten K
    Urol Int; 2007; 79(2):111-6. PubMed ID: 17851278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.